BRIEF published on 08/11/2026 at 12:35, 1 month 30 days ago Immunic, Inc. Reports Q2 2026 Financial Results and Updates Vidofludimus Calcium Leadership Appointments Multiple Sclerosis Trials Biotech Investments Immunic Financials
PRESS RELEASE published on 08/11/2026 at 12:30, 1 month 30 days ago Immunic, Inc. Reports Second Quarter 2026 Financial Results and Provides Corporate Update Immunic, Inc. reports Q2 2026 financial results and corporate update, with leadership team expansions and Phase 3 trials progress for vidofludimus calcium in MS Financial Results Corporate Update Immunic Inc. Vidofludimus Calcium Q2 2026
BRIEF published on 08/10/2026 at 22:10, 1 month 30 days ago Elena Ridloff rejoint le conseil d'administration d'Immunic en tant que directrice stratégique Vidofludimus Calcium Leadership En Biotechnologie Conseil D'immunisation Elena Ridloff Phase 3 ENSURE
BRIEF published on 08/10/2026 at 22:10, 1 month 30 days ago Elena Ridloff Joins Immunic's Board as Strategic Director Vidofludimus Calcium Immunic Board Elena Ridloff Biotechnology Leadership Phase 3 ENSURE
PRESS RELEASE published on 08/10/2026 at 22:05, 1 month 30 days ago Immunic Appoints Elena Ridloff to Board of Directors Immunic appoints Elena Ridloff, a financial and capital markets expert, to its Board of Directors, enhancing leadership as the company approaches pivotal phase 3 ENSURE Readout for Multiple Sclerosis treatments Board Of Directors Immunic Elena Ridloff MS Treatments ENSURE Readout
BRIEF published on 07/09/2026 at 12:35, 3 months 1 day ago Immunic annonce sa participation aux conférences investisseurs de juillet Biotechnologie Immunic Inc. Thérapies Orales Conférences D'investisseurs Maladies Neurologiques
BRIEF published on 07/09/2026 at 12:35, 3 months 1 day ago Immunic Announces Participation in July Investor Conferences Biotechnology Investor Conferences Immunic Inc. Oral Therapies Neurologic Diseases
PRESS RELEASE published on 07/09/2026 at 12:30, 3 months 1 day ago Immunic to Participate in Investor Conferences in July Immunic, Inc. (Nasdaq: IMUX) to participate in investor conferences in July, presenting at Leerink Partners Therapeutics Forum and B. Riley Securities Mind, Muscle & Vision Summit in Boston Investor Conferences Immunic Inc B. Riley Securities Neurologic Diseases Leerink Partners
BRIEF published on 06/10/2026 at 12:35, 4 months ago Immunic participe à des conférences clés en juin. Thérapies Orales Maladies Neurologiques Participation Immunitaire Conférences Sur La Biotechnologie Présentation De L'IMU-856
BRIEF published on 06/10/2026 at 12:35, 4 months ago Immunic Engages in Key Conferences this June Oral Therapies Neurologic Diseases Immunic Participation Biotechnology Conferences IMU-856 Presentation
Published on 10/10/2026 at 04:45, 9 hours 43 minutes ago Immutable Holdings and Jorge Masvidal's Gamebred Fighting Championship (FC) Enter Into Definitive Agreement for Proposed Reverse Takeover Transaction and Listing on the TSXV
Published on 10/10/2026 at 02:03, 12 hours 25 minutes ago BrandPilot AI Announces Closing of Previously Announced Debt Settlement
Published on 10/10/2026 at 02:00, 12 hours 28 minutes ago Battery X Metals Reports Estimated Driving Range Increase of Approximately 101 Kilometers Following a Single-Electric-Vehicle Performance Evaluation of Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Technology
Published on 10/09/2026 at 23:00, 15 hours 28 minutes ago Trans Canada Gold Closes First Tranche of Non-Brokered Private Placement for Gross Proceeds of CDN $2,144,720
Published on 10/09/2026 at 22:15, 16 hours 13 minutes ago Loop Industries to Host Second Quarter Fiscal 2027 Earnings Conference Call
Published on 10/10/2026 at 10:05, 4 hours 23 minutes ago ONLYOFFICE 10.0 brings AI tools, modular apps, and stronger security to its open-source office suite
Published on 10/09/2026 at 21:24, 17 hours 3 minutes ago Branicks Group AG: Extraordinary General Meeting does not approve all items on the agenda
Published on 10/09/2026 at 21:17, 17 hours 10 minutes ago EQS-Adhoc: Branicks Group AG: Agenda topic four at extraordinary general meeting rejected
Published on 10/09/2026 at 19:22, 19 hours 6 minutes ago EQS-Adhoc: elumeo SE switches financial reporting to comply with the German Commercial Code (HGB) and refines forecast for 2026
Published on 10/09/2026 at 19:27, 19 hours 1 minute ago Disclosure of transactions in own shares from October 1 to October 9, 2026
Published on 10/09/2026 at 19:27, 19 hours 1 minute ago Déclaration hebdomadaire d'opérations effectuées du 1er au 9 octobre 2026
Published on 10/09/2026 at 17:45, 20 hours 43 minutes ago Déclaration des droits de vote à fin septembre 2026
